- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05924893
The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer
June 20, 2023 updated by: Ahemd Abdelghany, Minia University
The opioid growth factor-receptor antagonist-naltrexone hydrochloride (NTX)- has gained much reach interest for applications in ophthalmology, because of its novel mechanism of action for speeding up corneal wound healing in both diabetics and non-diabetics, effective both locally and systemically and its availability as a low molecular weight synthetic drug.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Corneal epithelial defects generally heal within 2 days without complications, in some patients with decreased corneal sensitivity, such as patients with severe dry eye, corneal neuropathy, or autoimmune diseases, the corneal epithelium shows a reduced tendency for spontaneous healing Resistant corneal ulcers may appear as epithelial defects associated to Bowman's layer disruption with associated damage and partial variable loss of superficial corneal stroma larger than 2 mm in diameter that persist more than 2 weeks even treated with conventional treatment .
Noninfectious corneal ulcers have a similar clinical presentation like that of infectious ulcers but with no known infectious cause .
Resistant corneal ulcer can lead to serious complications such as infection, inflammation, corneal scarring, opacification, corneal thinning, and perforation .
In our study NTX accelerated healing of resistant corneal ulcers that was refractory to conventional treatment with lubricant eye drops and was safe with no complications reported in all treated eyes.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Minya, Egypt
- Faculty of medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- refractory non infective corneal ulcer
Exclusion Criteria:
- infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Naltrexone group
25 eyes with refractory non infective corneal ulcer were subjected to daily insertion of a NTX film in the lower conjunctival fornix for 2 weeks
|
naltrexone film
Other Names:
|
Experimental: Control
25 eyes with refractory non infective corneal ulcer were treated by carboxymethyl cellulose sodium 0.5 % eye drops
|
Carboxy methyl cellulose drops
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
healing of ulcer
Time Frame: 2 weeks
|
healing of ulcer measured in millemeters by clinical examination on slit lamp after staining with sodium fluorescein stain
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hossam Moharram, professor, Minia University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
June 1, 2022
Study Completion (Actual)
December 15, 2022
Study Registration Dates
First Submitted
June 11, 2023
First Submitted That Met QC Criteria
June 20, 2023
First Posted (Actual)
June 29, 2023
Study Record Updates
Last Update Posted (Actual)
June 29, 2023
Last Update Submitted That Met QC Criteria
June 20, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015 (American Sleep Medicine Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cornea Ulcer
-
Udayana UniversityCompletedErosion; Cornea, TraumaticIndonesia
-
Alaa GamalAl-Azhar UniversityCompleted
-
OptovueCompletedCataract Surgery | Normal Cornea | Post Laser Refractive Surgery | Cornea PathologyUnited States
-
Daniela NoschCompleted
-
National Taiwan University HospitalUnknown
-
Carl Zeiss Meditec, Inc.ClinReg Consulting Services, Inc.; Sierra Clinical Services, LLCCompleted
-
Augenarztpraxis BreisachUnknown
-
University of Missouri-ColumbiaUniversity of South FloridaRecruitingKeratoconus | Cornea EctasiaUnited States
-
Occyo GmbHUniversity Clinic for Ophthalmology and Optometry- SalzburgCompletedLimbal Stem-cell Deficiency | Cornea Disease | Eyes Dry Chronic | Chronic Conjunctivitis of Both Eyes | Eye Lesion | Eye Disease; Cataract | Eyes Dry Feeling of | Cornea Inflamed | Cornea; Injury, Abrasion | Cornea InfectionAustria
-
Case Western Reserve UniversityNational Eye Institute (NEI); Jaeb Center for Health ResearchCompletedCornea Preservation Time | Endothelial Keratoplasty | Transplant Success | Endothelial Cell DensityUnited States
Clinical Trials on Naltrexone Hydrochloride
-
San Diego State UniversityRecruitingPlacebo | NaltrexoneUnited States
-
Medical University of LublinRecruitingQuality of Life | Vulvodynia | NaltrexonePoland
-
PfizerTerminatedChronic PainUnited States
-
PfizerTerminatedModerate-severe PainUnited States
-
Timothy SmithCompleted
-
Yale UniversityNational Center for Responsible GamingCompleted
-
University of PennsylvaniaRecruitingGiant Cell Arteritis | Microscopic Polyangiitis | Polyarteritis Nodosa | Granulomatosis With Polyangiitis | Takayasu Arteritis | Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Churg-Strauss Syndrome (CSS)United States
-
Rosemary Claire RodenChildren's Miracle NetworkEnrolling by invitationBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
University of MiamiCompletedAlcohol Dependence | Bipolar DisorderUnited States